Ligand Pharmaceuticals | LGND - EPS - Lucro por Ação

Preço das Ações
202.33
Mudança Diária
-2.48 -1.21%
Mensal
7.05%
Anual
81.19%
Q1 Previsão
198.67

Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 1.82 1.33 May/06 2026
FY2025Q4 Dec/2025 2.02 1.49 1.27 Feb/26 2026
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06 2025
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07 2025
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08 2025




Eps Alterar Data
Agenus USD -0.3 0.84 2025-12
Amgen USD 5.29 0.35 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Baxter International USD 0.44 0.25 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Enviri Corporation USD -1.02 0.92 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -1.54 0.21 2025-12
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
MacroGenics USD -0.22 0.49 2025-12
Merck USD 2.04 0.54 2025-12
Pacira USD 0.06 0.64 2025-12
Pfizer USD 0.66 0.21 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Veracyte USD 0.53 0.02 2025-12